Blue Owl Capital shares are higher in Monday trading, with the move tied to fresh bullish commentary from TD Cowen. The firm reiterated its Buy rating while trimming its 12-month price target to $14 from $16, framing the pullback as an opportunity as long-term institutional demand for alternative assets remains intact despite near-term private-credit headline risk. (tradingview.com)

Blue Owl has been under pressure amid investor concerns about private-credit liquidity and redemptions, but the TD Cowen view is that the market is already pricing in an excessively negative scenario for parts of Blue Owl’s evergreen product complex. The note also pointed to liquidity as a cushion and argued the company should not be forced into distressed selling, even if near-term sentiment remains choppy. (tradingview.com)

With skepticism elevated across publicly traded alternatives managers, incremental positive research can have an outsized impact on a given day’s tape—especially when positioning is crowded and sentiment has been fragile. Separately, recent reports have highlighted a build in bearish positioning/short interest in the name, which can increase the odds of a sharper rebound on any supportive catalyst. (ad-hoc-news.de)